Annual EBIT
-$128.52 M
-$31.40 M-32.34%
December 31, 2021
Summary
- As of February 10, 2025, PHAS annual earnings before interest & taxes is -$128.52 million, with the most recent change of -$31.40 million (-32.34%) on December 31, 2021.
- During the last 3 years, PHAS annual EBIT has fallen by -$108.60 million (-545.14%).
Performance
PHAS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$16.55 M
-$5.56 M-50.54%
June 30, 2022
Summary
- As of February 10, 2025, PHAS quarterly earnings before interest & taxes is -$16.55 million, with the most recent change of -$5.56 million (-50.54%) on June 30, 2022.
- Over the past year, PHAS quarterly EBIT has increased by +$10.28 million (+38.31%).
Performance
PHAS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$102.17 M
+$10.28 M+9.14%
June 30, 2022
Summary
- As of February 10, 2025, PHAS TTM earnings before interest & taxes is -$102.17 million, with the most recent change of +$10.28 million (+9.14%) on June 30, 2022.
- Over the past year, PHAS TTM EBIT has increased by +$6.56 million (+6.03%).
Performance
PHAS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
PHAS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -32.3% | +38.3% | +6.0% |
| 3 y3 years | -545.1% | -83.6% | -167.7% |
| 5 y5 years | -1608.2% | -752.2% | -167.7% |
PHAS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +50.5% | +159.4% | at high | +25.8% |
| 5 y | 5-year | +236.7% | at low | +50.9% | +159.4% | +167.7% | +25.8% |
| alltime | all time | +1608.2% | at low | +1067.9% | +159.4% | +5161.0% | +25.8% |
PhaseBio Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$16.55 M(+50.5%) | -$102.17 M(-9.1%) |
| Mar 2022 | - | -$10.99 M(-74.4%) | -$112.44 M(-12.5%) |
| Dec 2021 | -$128.52 M(+32.3%) | -$42.92 M(+35.4%) | -$128.52 M(+11.1%) |
| Sep 2021 | - | -$31.70 M(+18.2%) | -$115.65 M(+6.4%) |
| Jun 2021 | - | -$26.82 M(-0.9%) | -$108.73 M(-0.9%) |
| Mar 2021 | - | -$27.07 M(-9.9%) | -$109.67 M(+12.9%) |
| Dec 2020 | -$97.12 M(+154.4%) | -$30.05 M(+21.3%) | -$97.12 M(+24.5%) |
| Sep 2020 | - | -$24.78 M(-10.7%) | -$78.04 M(+21.2%) |
| Jun 2020 | - | -$27.76 M(+91.1%) | -$64.38 M(+41.1%) |
| Mar 2020 | - | -$14.53 M(+32.5%) | -$45.63 M(+19.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$38.17 M(+91.6%) | -$10.97 M(-1.4%) | -$38.17 M(+19.7%) |
| Sep 2019 | - | -$11.13 M(+23.4%) | -$31.89 M(+14.8%) |
| Jun 2019 | - | -$9.01 M(+27.5%) | -$27.78 M(+15.8%) |
| Mar 2019 | - | -$7.07 M(+50.8%) | -$23.99 M(+20.4%) |
| Dec 2018 | -$19.92 M(+164.8%) | -$4.68 M(-33.2%) | -$19.92 M(+19.6%) |
| Sep 2018 | - | -$7.01 M(+34.1%) | -$16.65 M(+43.8%) |
| Jun 2018 | - | -$5.23 M(+74.3%) | -$11.59 M(+82.2%) |
| Mar 2018 | - | -$3.00 M(+111.6%) | -$6.36 M(+89.3%) |
| Dec 2017 | -$7.52 M(-18.4%) | -$1.42 M(-27.0%) | -$3.36 M(+73.0%) |
| Sep 2017 | - | -$1.94 M | -$1.94 M |
| Dec 2016 | -$9.22 M | - | - |
FAQ
- What is PhaseBio Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals annual EBIT year-on-year change?
- What is PhaseBio Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals quarterly EBIT year-on-year change?
- What is PhaseBio Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals TTM EBIT year-on-year change?
What is PhaseBio Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of PHAS is -$128.52 M
What is the all time high annual EBIT for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high annual earnings before interest & taxes is -$7.52 M
What is PhaseBio Pharmaceuticals annual EBIT year-on-year change?
Over the past year, PHAS annual earnings before interest & taxes has changed by -$31.40 M (-32.34%)
What is PhaseBio Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of PHAS is -$16.55 M
What is the all time high quarterly EBIT for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high quarterly earnings before interest & taxes is -$1.42 M
What is PhaseBio Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, PHAS quarterly earnings before interest & taxes has changed by +$10.28 M (+38.31%)
What is PhaseBio Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of PHAS is -$102.17 M
What is the all time high TTM EBIT for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high TTM earnings before interest & taxes is -$1.94 M
What is PhaseBio Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, PHAS TTM earnings before interest & taxes has changed by +$6.56 M (+6.03%)